---
document_datetime: 2026-01-23 09:04:20
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/byooviz-epar-all-authorised-presentations_en.pdf
document_name: byooviz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4258395
conversion_datetime: 2026-01-26 20:32:27.021353
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.70.0
  docling-core: 2.60.2
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                     |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------|---------------------------|-----------------------------------------------|
| EU/1/21/1572/001 | Byooviz           | 10 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)          | 0.23 ml                   | 1 vial + 1 filter needle + 1 injection needle |
| EU/1/21/1572/002 | Byooviz           | 10 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)          | 0.23 ml                   | 1 vial                                        |
| EU/1/21/1572/003 | Byooviz           | 10 mg/ml   | Solution for injection | Intravitreal use          | pre-filled syringe    | 0.165 ml                  | 1 pre-filled syringe                          |